Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks
BPC-157 503A September 29, 2023 Compounded drugs containing BPC-157 may pose risk for immunogenicity for certain routes of administration and may have complexities with regard to peptide-related impurities and active pharmaceutical ingredient (API) …